Melissa has over 20 years of experience in the pharmaceutical industry as a drug developer and business development professional. Melissa is currently Vice President and Head of Business Development for Immunology at GlaxoSmithKline. She has held previous positions in business development on the buy and sell side and across a range of therapeutic areas. Prior to this, she was privileged to spend 10 years successfully developing respiratory medicines at GlaxoSmithKline. Melissa has a Doctorate of Pharmacy from the Ohio State University, a BS in Pharmacy from West Virginia University and completed a specialty residency in infectious disease at the University of North Carolina, Chapel Hill.